Navigation Links
Ohr Pharmaceutical Announces Additions to Ophthalmic Scientific Advisory Board
Date:11/20/2012

NEW YORK, Nov. 20, 2012 /PRNewswire/ -- Ohr Pharmaceutical Inc. (OTCBB: OHRP) today announced the addition of two prominent ophthalmologists to its Scientific Advisory Board ("SAB") comprised of leading retinal ophthalmology experts to assist in advancing the Squalamine eye drop program through clinical efficacy trials. Jeffrey S. Heier, M.D. of Ophthalmic Consultants of Boston, and Daniel Roth, M.D., of Retina Vitreous Center in New Jersey will be joining as members of the SAB. These highly regarded experts will advise the company on its clinical programs, regulatory strategy and provide strategic guidance to support the development of Squalamine in multiple neovascular ophthalmic clinical indications, each with sizable commercial markets.

"Squalamine eye drops have the potential to significantly advance the treatment of wet-AMD, both from a patient's convenience perspective as well as its unique mechanism of action which may provide distinct or additional benefits from our current anti-VEGF agents," commented Dr. Jeffrey Heier. "I am excited to be participating in the current trial and look forward to working closely with the Ohr team on this exciting approach."

"We are delighted to be working with thought leaders in the retina community of the caliber of Drs. Heier and Roth," commented Irach B. Taraporewala, Ph.D., CEO. "The reaction of the retinal physician community to our ongoing phase II Squalamine eye drop clinical trial has been very enthusiastic. We will continue to utilize our distinguished SAB to further expand into additional neovascular ophthalmic indications."

Biography for each SAB member is below:

Dr. Jeffrey S. Heier is one of the leading retinal clinical researchers in the country for new treatments in exudative and non-exudative macular degeneration, diabetic macular edema, venous occlusive disease, vitreoretinal surgical techniques and instrumentation, and diagnostic imaging of the retina.  He serves on
'/>"/>

SOURCE Ohr Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Isis Pharmaceuticals To Present At The 24th Annual Piper Jaffray Healthcare Conference
2. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
3. Global Pharmaceuticals & Medicine Manufacturing
4. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
5. Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
6. Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
7. Clinical Trial Strategies to Ensure Pharmaceutical Success in a Global Marketplace
8. Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
9. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
10. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
11. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... IOMI ) today announced that Stanley C. Erck, the ... Acumen BioFin,Rodman & Renshaw 9th Annual Healthcare Conference in ... will begin at 9:10 a.m. Eastern,Time in the Kennedy ... Mr. Erck,s presentation will focus on Iomai,s portfolio of ...
... Exelixis, Inc. (Nasdaq:,EXEL) today presented data from ... with albuminuria due to diabetic nephropathy. XL784 is ... enzymes that may,play a role in the pathogenesis ... presented during a poster session (Abstract/Poster PO1030) at,the ...
Cached Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 2Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 3Phase 2 Trial Results for Exelixis' XL784 Presented at the 2007 American Society of Nephrology Conference 4
(Date:4/18/2014)... prepped to enter the battle against infectious disease. ... in remote areas, thanks in part to knowledge ... International Space Station on the behavior of liquids. ... flow to diagnose infectious diseases such as HIV/AIDS ... at Northwestern University in Evanston, Ill., had been ...
(Date:4/18/2014)... 160 years of neuroanatomy on its head. , Myelin, ... for the fast transmission of impulses along the axons ... according to a new work lead by Professor Paola ... the University,s Department of Stem Cell and Regenerative Biology, ... of Molecular and Cellular Biology. , "Myelin is a ...
(Date:4/18/2014)... worst memories? How did it make you feel? According ... personal experience, such as how sad you were or ... especially when you can,t stop thinking about it. ... the context of the memories, rather than how you ... alleviate the negative effects of these memories, a new ...
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/18/2014)... available in French . ... practice and regenerative medicine. A team led by Ludwik ... Paris Tech) and Didier Letourneur from the Laboratoire Recherche ... just demonstrated that the principle of adhesion by aqueous ... repair soft-tissue organs and tissues. This easy-to-use gluing method ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Scientists discover brain's anti-distraction system 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3
... has thus far spilled 50,000 gallons of industrial oil into the ... people in the area. The ship had sunk off the coast ... have fallen sick and one man has died as a result ... are the main complaints from the people so far. Petron Corp. ...
... Scotland as a part of a major new study that ... to be funded by Arthritis Research Campaign and people from ... the west of the Mainland of Orkney are expected to ... next three years. ,The investigation will be carried out ...
... researchers from the University of Michigan (U-M) medical school states ... lived longer. ,According to a new multicentre study ... led by researchers at the U-M Comprehensive Cancer Centre, that ... Journal of Clinical Oncology, has explained that a test that ...
... are successfully used only when they affect only the diseased ... Planck researchers attempted to direct microcapsules into cancer cells and ... They have succeeded in releasing a substance into the tumour ... small capsule and directing it into the tumour cells where ...
... Access Grid Toolkit developed at the U.S. Department of Energy’s ... Grid Toolkit is software that uses audio, video, data and ... they were at the same location. The Access Grid Toolkit ... downloads across 56 countries. The software is deployed in a ...
... the ban on smoking in public places would worsen health ... this week’s BMJ.// ,Smoking is the largest single cause ... with 106,000 people dying of smoking related diseases in 2002, ... of passive smoking. ,The Health Act 2006 will ...
Cached Medicine News:Health News:New Study To Identify Osteoporosis Genes 2Health News:PSA Can Predicts The Treatment Response In Advanced Prostate Cancer 2Health News:Microcapsules target cancer cells 2Health News:Microcapsules target cancer cells 3Health News:Latest Enhancements to the Free Access Grid Toolkit Now Available 2Health News:Latest Enhancements to the Free Access Grid Toolkit Now Available 3Health News:Mental Health Units Should not be Exempt from Smoking Ban 2
... / DVD Burner captures still images ... 50 patient archives allows for multiple ... retrieval. The unit provides software burned ... easy playback and editing. Compatible with ...
LCD monitors....
Camera and light source in one compact "Plug-and-Play" device....
... a highly sensitive DR system. It features ... it is designed for most general radiographic ... multiple wall stand and table configurations. , ... efficiently produces detailed patient images with reduced ...
Medicine Products: